Navigation Links
Auxilium Pharmaceuticals, Inc. To Present At The Goldman Sachs 34th Annual Global Healthcare Conference
Date:6/7/2013

CHESTERBROOK, Pa., June 7, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the Goldman Sachs 34th Annual Global Healthcare Conference to be held June 11-13, 2013 at the Terranea Hotel in Rancho Palos Verdes, CA.  Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 10:40 a.m. PT (1:40 p.m. ET) on Thursday, June 13, 2013.  

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO)

The presentation will also be webcast on the "For Investors" section of the Auxilium website under the "Events" tab on June 13, 2013.  To access the live webcast, please log on to Auxilium's website approximately fifteen minutes prior to the presentation to register and download any necessary audio software.  The presentation replay will be available for ninety days after the event.About Auxilium
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences.  Auxilium markets Testim® 1% (testosterone gel) for the topical treatment of hypogonadism in the U.S., XIAFLEX® (collagenase clostridium histolyticum (CCH)) for the treatment of adult Dupuytren's contracture patients with a palpable cord in the U.S., and distributes XIAPEX® (the EU tradename for CCH) in the European Union through Pfizer Inc. under a transition services agreement until the applicable marketing authorizations are fully transferred to Auxilium.  GlaxoSmithKline LLC co-promotes Testim with Auxilium in the U.S.  Ferring International Center S.A. markets Testi
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Auxilium, Inc. Launches Top-Tier Engineer Program
2. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
3. Auxilium Pharmaceuticals, Inc. to Present at the Leerink Swann Global Healthcare Conference
4. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Results and Conduct Conference Call on Tuesday, February 26, 2013
5. Auxilium Pharmaceuticals, Inc. to Present At The Oppenheimer 23rd Annual Growth Conference
6. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
7. Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
8. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
9. Auxilium Announces Appointments to Enhance Leadership Team
10. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
11. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... equipment, trained personnel, and detection dogs to safeguard ... A revolutionary new electronic chip with nano-sized chemical ... easier. , The groundbreaking nanotechnology-inspired sensor, devised by ... School of Chemistry and Center for Nanoscience and ... picks up the scent of explosives molecules better ...
(Date:7/24/2014)... 24, 2014 Research and Markets ... Culture Market 2014-2018" report to their offering.  ... culture is the in vitro growth of plant or ... studies, and biopharmaceutical production. Cell culture is a crucial ... instruments and cell culture consumables are necessary for the ...
(Date:7/24/2014)... Three companies from the angelMD network ... C Competition. Out of 700 competition entrants, Chiron Health, ... semi-final round. In this round twenty teams are invited ... with mentoring from thought-leaders and medical entrepreneurs from all ... angelMD commitment to the Livestrong vision around the Big ...
(Date:7/24/2014)... Canada (PRWEB) July 24, 2014 The ... Optimizing Dose Escalation in First in Human Studies” will ... make better go/no-go decisions. , With increasing R&D costs ... pharmaceutical companies need to maximize the knowledge collected in ... decisions and improve success in late stage development. , ...
Breaking Biology Technology:Nano-sized chip 'sniffs out' explosives far better than trained dogs 2Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
... experience in multi-GPU high-performance computing systems designed ... scientists, engineers and researchers with a GPU-based ... (PSC), which will be shown at the ... Conference, the top international conference for high ...
... the First Time , ... San Diego, CA (PRWEB) ... a regenerative medicine company developing solutions based on the products of ... of Regenerative Medicine conference, taking place November 17-18, 2008 in London. ...
... Henderson LLP, one of Canada,s Largest Law firms, has implemented a ... The firm has leveraged FileTrail Web Services to integrate physical records ... the Firm,s 2,000 employees. , ... San Jose, CA ...
Cached Biology Technology:BOXX Personal Supercomputer for Research Scientists Featured at SC08 2Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine 2Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine 3Gowlings Adopts RFID and Unifies Practice Management 2Gowlings Adopts RFID and Unifies Practice Management 3Gowlings Adopts RFID and Unifies Practice Management 4
(Date:7/27/2014)... like bacteria and fungi can evade treatment by acquiring ... drugs. These permanent mutations were once thought to be ... a new study has shown that microorganisms can use ... epimutations -- to gain the benefits of drug resistance ... discovered in a fungus called Mucor circinelloides, it is ...
(Date:7/27/2014)... Using data from over 18,000 patients, scientists have ... involved in Parkinson,s disease, including six that had ... Nature Genetics , was partially funded by ... by scientists working in NIH laboratories. , "Unraveling ... understanding the multiple mechanisms involved in this complex ...
(Date:7/25/2014)... and some of the smoke from those fires is drifting ... the Moderate Resolution Imaging Spectroradiometer (MODIS) aboard the Aqua satellite ... over the Great Lakes region of the United States. ... 23, 2014 (first image feature highlighted below) clearly shows the ... In the image, it is over Manitoba and parts ...
Breaking Biology News(10 mins):Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3NIH scientists find 6 new genetic risk factors for Parkinson's 2
... University Bloomington scientists will use knowledge about methane production ... in on evidence for similar, carbon-based microbes that could ... Saturn,s Enceladus. The three-year project, funded by a ... for Exploring Planets (ASTEP) program, will be led by ...
... are being found increasingly in the environmentand in environmental ... properties, especially as antibacterial and antifungal agents, silver nanoparticles ... industrial and consumer products. This, in turn, has raised ... the environment. Now a new research paper* adds an ...
... on the long-awaited era of the "$1,000 genome" a time ... deciphered for about that amount compared to nearly $1 million ... of Chemical & Engineering News (C&EN), ACS, weekly newsmagazine, raises the ... estimate, is necessary to analyze that genetic data so it can ...
Cached Biology News:NASA project eyes climate change in Greenland -- with a third eye on Mars 2NASA project eyes climate change in Greenland -- with a third eye on Mars 3Silver cycle: New evidence for natural synthesis of silver nanoparticles 2
... Data System (CDS) now provides integrated ... data processing and reporting for the ... The companys innovative HPLC instrument has ... of Thermo Scientific Hypersil GOLD 1.9 ...
...
...
... Exiqon's miRCURY LNA technology enables sensitive ... Northern blotting. miRCURY LNA Detection probes have ... specific and sensitive detection of miRNAs. Due ... miRCURY LNA probes less than 1/10 the ...
Biology Products: